Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang C Winkelmayer

Showing results (1-10 of 488) with videos related to

Pageof 49
Sort By:
JAMA|July 15, 2015
Treatment of Hyperkalemia: From "Hyper K+" Strikeout to Home Run?Wolfgang C Winkelmayer
Seminars in Dialysis|November 12, 2010
Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysisWolfgang C Winkelmayer
Journal of the American Society of Nephrology : JASN|December 18, 2010
Against TREATing all patients alike: lessons from an FDA Advisory Committee MeetingWolfgang C Winkelmayer
Blood Purification|January 14, 2011
Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage renal disease careWolfgang C Winkelmayer
Annals of Internal Medicine|September 16, 2014
Review: In CKD, novel oral anticoagulants do not differ from vitamin K antagonists for efficacy or bleedingWolfgang C Winkelmayer
Journal of the American Society of Nephrology : JASN|April 25, 2009
Lessons from geographic variations in predialysis nephrology careWolfgang C Winkelmayer
Nature Reviews. Nephrology|March 20, 2014
Cardiovascular disease: Still unresolved: warfarin in ESRD with atrial fibrillationWolfgang C Winkelmayer
Circulation|December 21, 2011
What caused excess strokes in patients randomized to darbepoetin in the trial to reduce cardiovascular events with Aranesp therapy (TREAT)?: no smoking gunWolfgang C Winkelmayer
The New England Journal of Medicine|January 28, 2011
Tackling the Achilles' heel of hemodialysisWolfgang C Winkelmayer
ACP Journal Club|March 17, 2006
Incidence of end-stage renal disease in patients with type 1 diabetes was 7.8% at 30 years after diagnosisWolfgang C Winkelmayer
Pageof 49

Showing results (1-10 of 488) with videos related to

Sort By:
Pageof 49
JAMA|July 15, 2015
Treatment of Hyperkalemia: From "Hyper K+" Strikeout to Home Run?Wolfgang C Winkelmayer
Seminars in Dialysis|November 12, 2010
Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysisWolfgang C Winkelmayer
Journal of the American Society of Nephrology : JASN|December 18, 2010
Against TREATing all patients alike: lessons from an FDA Advisory Committee MeetingWolfgang C Winkelmayer
Blood Purification|January 14, 2011
Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage renal disease careWolfgang C Winkelmayer
Annals of Internal Medicine|September 16, 2014
Review: In CKD, novel oral anticoagulants do not differ from vitamin K antagonists for efficacy or bleedingWolfgang C Winkelmayer
Journal of the American Society of Nephrology : JASN|April 25, 2009
Lessons from geographic variations in predialysis nephrology careWolfgang C Winkelmayer
Nature Reviews. Nephrology|March 20, 2014
Cardiovascular disease: Still unresolved: warfarin in ESRD with atrial fibrillationWolfgang C Winkelmayer
Circulation|December 21, 2011
What caused excess strokes in patients randomized to darbepoetin in the trial to reduce cardiovascular events with Aranesp therapy (TREAT)?: no smoking gunWolfgang C Winkelmayer
The New England Journal of Medicine|January 28, 2011
Tackling the Achilles' heel of hemodialysisWolfgang C Winkelmayer
ACP Journal Club|March 17, 2006
Incidence of end-stage renal disease in patients with type 1 diabetes was 7.8% at 30 years after diagnosisWolfgang C Winkelmayer
Pageof 49